Ichor is developing strategic products by incorporating the TriGrid® for delivery of nucleic acid candidates into two broad categories

Nucleic Acid Vaccines / Immunotherapeutics
  • Alternative to traditional vaccine approaches
    • Prophylaxis of infectious pathogens
  • Immunotherapy / novel vaccine indications
    • Oncology
    • Chronic viral infection
    • Autoimmune disease, Alzheimer’s disease, allergy
Protein / Monoclonal antibody (mAb) delivery
  • Alternative to systemic delivery of recombinants
    • Approved and/or novel agents
    • Low cost, sustained passive immunity (mAb)
  • Locoregional protein expression
    • Growth factors for revascularization / wound healing
    • Immunomodulators

By providing a means for safe, effective and reproducible in vivo nucleic acid delivery, Ichor TriGrid® Delivery System is positioned to be an essential component for addressing key hurdles associated with nucleic acid-based medicines in the clinical setting for a variety of disease indications.